Mraz Amerine & Associates’s Sanofi SNY Stock Holding History

Mraz Amerine & Associates’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,100	Closed	-$206K	–	170
2020 Q3	$206K	Hold	4,100	–	–	0.08%	133
2020 Q2	$209K	Sell	4,100 -1,000	-20%	-$48.6K	0.08%	126
2020 Q1	$223K	Hold	5,100	–	–	0.09%	110
2019 Q4	$256K	Hold	5,100	–	–	0.07%	136
2019 Q3	$236K	Hold	5,100	–	–	0.07%	140
2019 Q2	$221K	Hold	5,100	–	–	0.07%	143
2019 Q1	$226K	Sell	5,100 -400	-7%	-$17.1K	0.07%	138
2018 Q4	$239K	Sell	5,500 -200	-4%	-$8.82K	0.08%	131
2018 Q3	$255K	Sell	5,700 -221	-4%	-$9.44K	0.08%	134
2018 Q2	$237K	Buy	+5,921	New	+$233K	0.07%	138
2017 Q4	–	Sell	-4,095	Closed	-$204K	–	161
2017 Q3	$204K	Buy	+4,095	New	+$198K	0.06%	135

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mraz Amerine & Associates's SNY Position: Q4 2020 in Review

Mraz Amerine & Associates sold out of Sanofi (SNY) in Q4 2020, closing a stake of 4,100 shares — an estimated $206K sold.

Mraz Amerine & Associates first reported a position in SNY in Q3 2017 and held it in 11 quarters. The position peaked at $256K in Q4 2019. 603 funds tracked by Wall St. Rank hold SNY as of Q4 2020.

Mraz Amerine & Associates reported no remaining Sanofi position as of Q4 2020 after selling out during the quarter.
Mraz Amerine & Associates sold 4,100 Sanofi shares in Q4 2020, an estimated $206K.
Mraz Amerine & Associates first reported a position in Sanofi in Q3 2017 and held it in 11 quarters.
Mraz Amerine & Associates's Sanofi position peaked at $256K in Q4 2019.
603 funds tracked by Wall St. Rank held Sanofi as of Q4 2020.

Based on Mraz Amerine & Associates's 13F filing for Q4 2020, filed 11 Feb 2021.